204 related articles for article (PubMed ID: 37111658)
1. Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines.
Kairuz D; Samudh N; Ely A; Arbuthnot P; Bloom K
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111658
[TBL] [Abstract][Full Text] [Related]
2. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.
Lou G; Anderluzzi G; Schmidt ST; Woods S; Gallorini S; Brazzoli M; Giusti F; Ferlenghi I; Johnson RN; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2020 Sep; 325():370-379. PubMed ID: 32619745
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens.
Snoeck J; Chiers K; Tam Y; Sanders NN; Garmyn A
Poult Sci; 2023 Nov; 102(11):103078. PubMed ID: 37801866
[TBL] [Abstract][Full Text] [Related]
4. Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA.
Blakney AK; McKay PF; Yus BI; Aldon Y; Shattock RJ
Gene Ther; 2019 Sep; 26(9):363-372. PubMed ID: 31300730
[TBL] [Abstract][Full Text] [Related]
5. Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines.
Blakney AK; McKay PF; Hu K; Samnuan K; Jain N; Brown A; Thomas A; Rogers P; Polra K; Sallah H; Yeow J; Zhu Y; Stevens MM; Geall A; Shattock RJ
J Control Release; 2021 Oct; 338():201-210. PubMed ID: 34418521
[TBL] [Abstract][Full Text] [Related]
6. Efficient
Opsomer L; Jana S; Mertens I; Cui X; Hoogenboom R; Sanders NN
J Mater Chem B; 2024 Apr; 12(16):3927-3946. PubMed ID: 38563779
[TBL] [Abstract][Full Text] [Related]
7. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
8. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.
Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2022 Feb; 342():388-399. PubMed ID: 34896446
[TBL] [Abstract][Full Text] [Related]
9. Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach.
Ly HH; Daniel S; Soriano SKV; Kis Z; Blakney AK
Mol Pharm; 2022 Jun; 19(6):1892-1905. PubMed ID: 35604765
[TBL] [Abstract][Full Text] [Related]
10. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
11. Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19.
Silva-Pilipich N; Beloki U; Salaberry L; Smerdou C
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543952
[TBL] [Abstract][Full Text] [Related]
12. Vaccines' New Era-RNA Vaccine.
Zhou W; Jiang L; Liao S; Wu F; Yang G; Hou L; Liu L; Pan X; Jia W; Zhang Y
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632102
[TBL] [Abstract][Full Text] [Related]
13. Advanced nanoscale delivery systems for mRNA-based vaccines.
Mobasher M; Ansari R; Castejon AM; Barar J; Omidi Y
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130558. PubMed ID: 38185238
[TBL] [Abstract][Full Text] [Related]
14. The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants.
Blakney AK; McKay PF; Ibarzo Yus B; Hunter JE; Dex EA; Shattock RJ
ACS Nano; 2019 May; 13(5):5920-5930. PubMed ID: 31046232
[TBL] [Abstract][Full Text] [Related]
15. A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety.
Bae SH; Yoo S; Lee J; Park HJ; Kwon SP; Jin H; Park SI; Lee YS; Bang YJ; Roh G; Lee S; Youn SB; Kim IW; Oh HR; El-Damasy AK; Keum G; Kim H; Youn H; Nam JH; Bang EK
Bioact Mater; 2024 Aug; 38():486-498. PubMed ID: 38779592
[TBL] [Abstract][Full Text] [Related]
16. LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing.
Xue Y; Zhang Y; Zhong Y; Du S; Hou X; Li W; Li H; Wang S; Wang C; Yan J; Kang DD; Deng B; McComb DW; Irvine DJ; Weiss R; Dong Y
Nat Commun; 2024 Jan; 15(1):739. PubMed ID: 38272900
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Review of mRNA Vaccines.
Gote V; Bolla PK; Kommineni N; Butreddy A; Nukala PK; Palakurthi SS; Khan W
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769023
[TBL] [Abstract][Full Text] [Related]
18. Polyplex nanomicelle delivery of self-amplifying RNA vaccine.
Chang YH; Lin MW; Chien MC; Ke GM; Wu IE; Lin RL; Lin CY; Hu YC
J Control Release; 2021 Oct; 338():694-704. PubMed ID: 34509585
[TBL] [Abstract][Full Text] [Related]
19. Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA.
Blakney AK; McKay PF; Christensen D; Yus BI; Aldon Y; Follmann F; Shattock RJ
J Control Release; 2019 Jun; 304():65-74. PubMed ID: 31071377
[TBL] [Abstract][Full Text] [Related]
20. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach.
Young RE; Nelson KM; Hofbauer SI; Vijayakumar T; Alameh MG; Weissman D; Papachristou C; Gleghorn JP; Riley RS
Bioact Mater; 2024 Apr; 34():125-137. PubMed ID: 38223537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
